Kestra Medical Technologies Ltd (KMTS) Stock Price, Quote & News

Company Profile

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its p...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 425 279 8002

Website: kestramedical.com

Address:

3933 Lake Washington Blvd NE, Suite 200, Kirkland, United States

EarningsInsider Jul. 14 at 9:46 PM

https://www.marketbeat.com/earnings/reports/2026-7-14-kestra-medical-technologies-ltd-stock/ $KMTS Kestra Medical Technologies Earnings Tr

0 · Reply

healthcareguru Jul. 14 at 9:04 PM

$KMTS woof…these analysts not liking the Rx guide for FY27… Gonna have the stock down. Nobody likes messy.

1 · Reply

StocktwitsEarnings Jul. 14 at 8:31 PM

$KMTS Q4 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.67 up 69.68% YoY • Reported revenue of $28.64M up 66.18% YoY • Kestra Medical Technologies expects revenue of $137 million in fiscal year 2027, which would represent growth of 44% compared to the revenue reported for the fiscal year ended April 30, 2026.

0 · Reply

healthcareguru Jul. 14 at 8:06 PM

$KMTS meh…declining magnitude of beat and bigger than expected profit losses. Modest guide ahead is non-event given insanity valuation and PE still looking to dump ~60% of the outstanding stock. Still only worth ~$5. 👎 $XLV $IHI $IWM $XBI

0 · Reply

deedeethegenius Jul. 14 at 4:11 PM

$KMTS $LOOP $AEHR

0 · Reply

SuperGreenToday May. 28 at 2:19 PM

$KMTS

0 · Reply

PenkeInvesting Mar. 19 at 7:17 PM

Fundamental analysis of $KMTS (KESTRA MEDICAL TECHNOLOGIES, LTD.) based on financial data and reported results. #KMTS

0 · Reply

BioGem Mar. 19 at 6:29 AM

$KMTS Very shortable at anything above $20. Critically wounded stock. With 58.5M shares and mkt cap of 1.17B, this is an extreme bubble valuation (Check multiples). -Revenue growth is quickly slowing QOQ. Market is niche and tough to displace legacy competitors. -Operating expenses are skyrocketing, operating losses are deeper, and cash burn is unsustainable. -Cash is quickly dwindling; they need to dilute again before any breakeven. -Many millions of vested options are in the money = dilution. -Expensive debt with hefty interest costs. -Short interest is rapidly rising. -New IPO and insiders will be selling soon.

1 · Reply

StocktwitsEarnings Mar. 17 at 8:10 PM

$KMTS Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.61 up 51.20% YoY • Reported revenue of $24.55M up 62.70% YoY • Kestra Medical Technologies Ltd. increased its FY26 revenue guidance to $93M, representing 55% growth compared to FY25, an increase from prior guidance of $91M and initial guidance of $85M.

0 · Reply

healthcareguru Mar. 12 at 5:30 PM

$KMTS cya at $2… 👎

1 · Reply

Kestra Medical price target raised to $32 from $30 at BTIG

Jul 14, 2026, 4:30 PM EDT - 3 days ago

Kestra Medical Technologies Earnings Call Transcript: Q4 2026

Jul 14, 2026, 4:30 PM EDT - 3 days ago

Kestra Medical Technologies Earnings release: Q4 2026

Jul 14, 2026, 4:30 PM EDT - 3 days ago

Kestra Medical Technologies Annual report: Q4 2026

Jul 14, 2026, 4:05 PM EDT - 3 days ago

Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing

Jul 14, 2026, 4:01 PM EDT - 3 days ago

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Jul 14, 2026, 7:00 AM EDT - 4 days ago

Kestra Medical Technologies Slides: Company presentation

Jun 30, 2026, 4:05 PM EDT - 17 days ago

Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14

May 13, 2026, 5:20 PM EDT - 2 months ago

Kestra Medical Technologies Transcript: Bank of America Global Healthcare Conference 2026

Apr 29, 2026, 6:00 AM EDT - 2 months ago

Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference

Apr 22, 2026, 8:00 AM EDT - 3 months ago

Kestra Showcases Accelerated Innovation at HRS 2026

2026-04-13T12:02:12.000Z - 3 months ago

Kestra Medical price target lowered to $30 from $32 at BTIG

Apr 9, 2026, 8:00 AM EDT - 3 months ago

Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner

2026-04-01T20:40:16.000Z - 3 months ago

Kestra Medical files automatic common shares offering

Mar 25, 2026, 8:00 AM EDT - 4 months ago

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”

Mar 17, 2026, 4:30 PM EDT - 4 months ago

Kestra Medical Technologies Earnings Call Transcript: Q3 2026

Mar 17, 2026, 4:30 PM EDT - 4 months ago

Kestra Medical Technologies Quarterly report: Q3 2026

Mar 17, 2026, 4:30 PM EDT - 4 months ago

Kestra Medical Technologies Earnings release: Q3 2026

Mar 17, 2026, 4:01 PM EDT - 4 months ago

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

Mar 17, 2026, 7:00 AM EDT - 4 months ago

Kestra Medical Technologies Slides: Company presentation

Mar 3, 2026, 6:00 AM EST - 4 months ago

Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17

2026-01-16T12:06:50.000Z - 6 months ago

Kestra Medical price target lowered to $24 from $27 at Goldman Sachs

Jan 13, 2026, 5:15 PM EST - 6 months ago

Kestra Medical Technologies Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-13T11:12:14.000Z - 6 months ago

Kestra Medical announces strategic collaboration with Biobeat Technologies

Jan 13, 2026, 6:00 AM EST - 6 months ago

Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery

2026-01-09T10:56:10.000Z - 6 months ago

Kestra Medical price target raised to $27 from $25 at Goldman Sachs

Dec 30, 2025, 6:00 AM EST - 7 months ago

Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

2025-12-13T00:10:11.000Z - 7 months ago

Kestra Medical price target raised to $25 from $22 at Goldman Sachs

2025-12-12T17:05:51.000Z - 7 months ago

Kestra Medical price target raised to $30 from $28 at Stifel

2025-12-12T12:55:28.000Z - 7 months ago

Kestra Medical price target raised to $28 from $27 at Wells Fargo

2025-12-12T12:05:28.000Z - 7 months ago

Kestra Medical price target raised to $30 from $27 at Piper Sandler

Dec 11, 2025, 4:30 PM EST - 7 months ago

Kestra Medical Technologies Earnings Call Transcript: Q2 2026

Dec 11, 2025, 4:30 PM EST - 7 months ago

Kestra Medical Technologies Quarterly report: Q2 2026

Dec 11, 2025, 4:30 PM EST - 7 months ago

Kestra Medical Technologies Earnings release: Q2 2026

Dec 11, 2025, 4:01 PM EST - 7 months ago

Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results

Dec 11, 2025, 7:00 AM EST - 7 months ago

Kestra Medical Technologies Slides: Company presentation

Dec 3, 2025, 8:00 AM EST - 8 months ago

Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results

Dec 2, 2025, 10:11 PM EST - 8 months ago

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares

Dec 1, 2025, 7:16 AM EST - 8 months ago

Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares

Dec 1, 2025, 7:01 AM EST - 8 months ago

Kestra Medical Technologies Reports Preliminary Second Quarter Fiscal 2026 Financial Results

Dec 1, 2025, 7:00 AM EST - 8 months ago

Kestra Medical Technologies Registration statement: Registration Filing

Nov 11, 2025, 3:20 PM EST - 8 months ago

Kestra Medical Technologies Transcript: Stifel 2025 Healthcare Conference

Nov 10, 2025, 9:52 AM EST - 8 months ago

Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra's ASSURE Device

Nov 4, 2025, 8:00 AM EST - 9 months ago

Kestra Medical Technologies to Present Late-Breaking ACE-PAS Trial Results at AHA 2025, Showcasing Next-Generation Wearable Defibrillator System

Oct 28, 2025, 8:00 AM EDT - 9 months ago

Kestra Medical Technologies to Present at the Stifel 2025 Healthcare Conference

Oct 7, 2025, 8:00 AM EDT - 10 months ago

Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth

Sep 25, 2025, 8:00 AM EDT - 10 months ago

Kestra Showcases Cardiac Recovery System Platform at HFSA 2025, Redefining Sudden Cardiac Arrest Risk Management

Sep 17, 2025, 8:00 AM EDT - 10 months ago

Kestra Medical Technologies Appoints Dr. Elizabeth Kwo to Board of Directors

Sep 15, 2025, 7:00 AM EDT - 10 months ago

Kestra Medical Technologies Slides: Company Presentation

Sep 11, 2025, 4:30 PM EDT - 11 months ago

Kestra Medical Technologies Earnings Call Transcript: Q1 2026

Sep 11, 2025, 4:30 PM EDT - 11 months ago

Kestra Medical Technologies Quarterly report: Q1 2026

Sep 11, 2025, 4:30 PM EDT - 11 months ago

Kestra Medical Technologies Earnings release: Q1 2026

Sep 11, 2025, 4:01 PM EDT - 11 months ago

Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results

Aug 28, 2025, 8:00 AM EDT - 11 months ago

Kestra Medical Technologies, Ltd. to Report First Quarter Fiscal 2026 Financial Results

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies Proxy statement: Proxy Filing

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies Proxy statement: Proxy Filing

Jul 17, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies Wins 2025 Top Workplaces Industry Award, A National Recognition

Jul 15, 2025, 4:30 PM EDT - 1 year ago

Kestra Medical Technologies Earnings Call Transcript: Q4 2025

Jul 15, 2025, 4:30 PM EDT - 1 year ago

Kestra Medical Technologies Annual report: Q4 2025

Jul 15, 2025, 4:30 PM EDT - 1 year ago

Kestra Medical Technologies Earnings release: Q4 2025

Jul 15, 2025, 4:01 PM EDT - 1 year ago

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Jul 1, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies, Ltd. to Report Fourth Quarter and Fiscal Year 2025 Results on July 15

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies Announces Inclusion in the Russell 2000® and Russell 3000® Indexes

Jun 11, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors

May 14, 2025, 6:40 PM EDT - 1 year ago

Kestra Medical Technologies Transcript: Bank of America 2025 Healthcare Conference

May 13, 2025, 8:00 AM EDT - 1 year ago

Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies to Participate in Upcoming Investor Conferences

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025

Apr 14, 2025, 4:30 PM EDT - 1 year ago

Kestra Medical Technologies Earnings Call Transcript: Q3 2025

Apr 14, 2025, 4:30 PM EDT - 1 year ago

Kestra Medical Technologies Quarterly report: Q3 2025

Apr 14, 2025, 4:30 PM EDT - 1 year ago

Kestra Medical Technologies Earnings release: Q3 2025

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

Mar 14, 2025, 4:05 PM EDT - 1 year ago

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering

Mar 7, 2025, 5:30 PM EST - 1 year ago

Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering

Mar 6, 2025, 10:43 AM EST - 1 year ago

Kestra Medical Technologies raises $202M in IPO, prices shares above expected range

Mar 5, 2025, 11:03 PM EST - 1 year ago

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering

Mar 3, 2025, 7:00 AM EST - 1 year ago

Kestra Medical Technologies Registration statement: Registration Filing

Feb 27, 2025, 11:23 AM EST - 1 year ago

Kestra Medical Technologies aims to raise $150M in IPO

Feb 26, 2025, 8:00 AM EST - 1 year ago

Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering

EarningsInsider Jul. 14 at 9:46 PM

https://www.marketbeat.com/earnings/reports/2026-7-14-kestra-medical-technologies-ltd-stock/ $KMTS Kestra Medical Technologies Earnings Tr

0 · Reply

healthcareguru Jul. 14 at 9:04 PM

$KMTS woof…these analysts not liking the Rx guide for FY27… Gonna have the stock down. Nobody likes messy.

1 · Reply

StocktwitsEarnings Jul. 14 at 8:31 PM

0 · Reply

healthcareguru Jul. 14 at 8:06 PM

0 · Reply

deedeethegenius Jul. 14 at 4:11 PM

$KMTS $LOOP $AEHR

0 · Reply

SuperGreenToday May. 28 at 2:19 PM

$KMTS

0 · Reply

PenkeInvesting Mar. 19 at 7:17 PM

Fundamental analysis of $KMTS (KESTRA MEDICAL TECHNOLOGIES, LTD.) based on financial data and reported results. #KMTS

0 · Reply

BioGem Mar. 19 at 6:29 AM

1 · Reply

StocktwitsEarnings Mar. 17 at 8:10 PM

0 · Reply

healthcareguru Mar. 12 at 5:30 PM

$KMTS cya at $2… 👎

1 · Reply

Twister8 Mar. 10 at 6:33 PM

$KMTS whats the word on the street?

0 · Reply

BillionerOfKing Feb. 26 at 4:26 AM

$KMTS Current Stock Price: $25.21

0 · Reply

jimbecker Feb. 10 at 3:24 PM

$KMTS Stage 1b(2) Double Bottom pattern with a pivot @ $28.84.

0 · Reply

InflLink Feb. 4 at 2:01 PM

$KMTS is a manufacturer of plastic pipe and conduit for infrastructure and construction; demand is tied to non-residential construction and utility spending, which have been resilient.

0 · Reply

ZacksResearch Jan. 14 at 6:04 PM

$KMTS just made a smart move in cardiac recovery — here’s why it matters. Kestra signed an exclusive partnership with Biobeat, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery. That’s a meaningful upgrade to diagnostic insight where it counts most. ⚕️📈 See how this partnership could change post-cardiac care 👉 https://www.zacks.com/stock/news/2817450/kmts-biobeat-partner-to-expand-diagnostic-insight-in-cardiac-recovery?cid=sm-stocktwits-2-2817450-teaser-28940&ADID=SYND_STOCKTWITS_TWEET_2_2817450_TEASER_28940

2 · Reply

ZacksResearch Jan. 14 at 5:04 PM

$KMTS dips 5.9% despite a promising partnership — what's happening? 🤔 Kestra is teaming up with Biobeat to enhance cardiac recovery tech, investing $5M in their Series B. Yet, shares fell, even as KMTS climbed 42.8% in 6 months. The company has a market cap of $1.37 billion and carries a Zacks Rank #4 (Sell). Find out what this means for investors here 👉 https://www.zacks.com/stock/news/2817450/kmts-biobeat-partner-to-expand-diagnostic-insight-in-cardiac-recovery?cid=sm-stocktwits-2-2817450-body-28941&ADID=SYND_STOCKTWITS_TWEET_2_2817450_BODY_28941

0 · Reply

prismmarketview Jan. 13 at 3:24 PM

Kestra Medical Technologies (Nasdaq: $KMTS) has entered a strategic collaboration with Biobeat that gives it exclusive rights to integrate Biobeat’s FDA‑cleared, cuffless ambulatory blood pressure monitoring tech into the ASSURE wearable defibrillator platform, adding 24‑hour hypertension and recovery insights for high‑risk cardiac patients. https://prismmarketview.com/kestra-medical-technologies-announces-strategic-collaboration-to-advance-interventional-oncology-innovation/

0 · Reply

GatsbyGains Dec. 25 at 8:39 AM

$KMTS Upside depends on translating ambition into measurable cadence, given the heightened sensitivity to timeline slippage. A coherent operating roadmap would be catalytic.

0 · Reply

SocioCobb Dec. 20 at 1:10 AM

$KMTS 6 mos swing… 2 banger, coming soon.

1 · Reply

Market Cap	1.41B
Revenue (ttm)	59.82M
Net Income (ttm)	-113.81M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-190.25%
Debt to Equity Ratio	0.15

Volume	339,700
Avg Vol	377,354
Day's Range	N/A - N/A
Shares Out	58.60M
Stochastic %K	44%
Beta	0.47
Analysts	Strong Sell
Price Target	$28.14